Since 2015, Onkos has been working on research and development of state-of-the-art medical technologies,
together with some of the largest centers of excellence in Brazil and in the world. Check out a summary of our history below.
Cancer Hospital of Barretos and Supera Parque.
01Development of the mir-THYpe test (PIPE 1 Fapesp)
02Development of a classifier for prostate cancer (PIPE 1 Fapesp)
03Laboratory inside USP Ribeirão Preto.
04Market launch of mir-THYpe.
05Own laboratory in Ribeirão Preto and partnership with Eretz Bio
06Optimization of the mir-THYpe test (PIPE 2 Fapesp)
07Publication in the journal Thyroid (belonging to the American Thyroid Association - ATA) of the results of the development and validation of the mir-THYpe test
08Launch of BRAF V600E + TERT mutations in mir-THYpe.
09Move to a new 600m2 laboratory in Ribeirão Preto.
10Development of a classifier for medullary thyroid cancer (PIPE1 Fapesp).
11Market expansion for mir-THYpe (PIPE3 Fapesp).
12Launch of the mir-THYpe pre-op molecular test.
13Study published in The LANCET Discovery Science (eBioMedicine).
14Optimization of the mir-THYpe algorithm.
15Development of test of tumor origin (PIPE 2 FAPESP).
16Launch of the new molecular tests mir-THYpe target and mir-THYpe RET-hereditary.
17Launch of the new brand mir-THYpe.
18Conclusion of PIPE 3 (FAPESP).
19